What Made Detransitioners Know Their Transition Was a Mistake
At 16 they cut off my breasts, pumped me with testosterone and promised happiness. At 20 I woke up sterile, sick and suing the people who sold me this lie. Teen transition isn’t care—it’s a life-long trap.
Overview
Luka Hein recounts four years of testosterone use and a double mastectomy at 16, which thrust her into chemically induced menopause, emotional numbness, and distorted sexuality—all while doctors assured her happiness that never came. By 20, she faced irreversible health damage, the longing for children, and the grim awareness that she had been bound to a medical system. Now, she is taking legal action against the clinicians who led her down that path and apologizing to her mother, whose warnings she once dismissed.
Full Video Summary
Luka Hein, a young woman who underwent a double mastectomy at 16 and then took testosterone for four years, describes her transition as a period of chemically induced chaos that left her emotionally disconnected from herself and the world around her. Speaking with Mary Margaret Olohan, Hein explains that the testosterone altered her voice, skin, hair, and body, while also thrusting her teenage body into a state akin to chemically induced menopause. Although she tried to convince herself she was happy—buoyed by the affirmations of doctors, therapists, and peers—she now recognizes that this was largely a placebo effect. The steroid energy from testosterone, combined with psychiatric medications, masked a deeper dissociation that she only fully grasped after detransitioning. During the four years she lived as male, Hein says she was too disassociated to form any serious romantic relationships. Sexual trauma that had gone unaddressed was eclipsed by the gender narrative, while the wrong-sex hormones and psychoactive drugs warped her natural drives. She recalls being a straight girl at 15, but once the medical pathway began, attraction became confusing and distorted. Without any model of healthy intimacy and with her body flooded with testosterone, she found it impossible to envision or experience real partnership; the idea of dating felt as remote as the idea of feeling at home in her own skin. The moment of clarity arrived not through a single dramatic trigger, but through the simple, painful process of growing up. At 20, Hein began asking adult questions—whether she wanted children, what kind of relationships she hoped for, how long she wished to remain tethered to an industry that required lifelong medication. Health complications from testosterone and a yearning for freedom converged: “I don’t want to be chained to a medical industry.” She contrasts her experience with that of other detransitioners, such as Helena Kerschner, whose “light-bulb” moment came when a slideshow revealed how sad she had become. For Hein, the realization was incremental: the promised happiness never materialized, and the medical narrative that “the other side” of transition would bring joy began to feel like a cruel sales pitch. Hein is now suing the therapist who first affirmed her, the gender-clinic physician who prescribed hormones, and the surgeon who removed her breasts. She describes telling her mother—who had voiced reservations that were overruled by clinicians—as “the emotional equivalent of slapping her in the face,” because it forced both of them to confront that maternal instinct had been right all along. The conversation was painful, but it also marked a return to the protective relationship that the gender clinic had sidelined.